India Patent Cases
2,823 decisions indexed
Page 68 of 95 · 2,823 total
Starbucks Corporation v.Mr.Sunil & Ors.
The Delhi High Court decreed the suit in favor of Starbucks Corporation against Defendant No. 5 following a joint settlement agreement. The settlement confirmed that Starbucks owns registered trademarks (STARBUCKS, FRAPPUCCINO) and copyrights in its logos and artistic works. In exchange for a payment of Rs. 37,500/-, the defendant agreed to permanent injunctions restraining them from infringing or misusing these marks and copyrights, including ceasing the sale of counterfeit products.
Pranathmaka Ayurvedics Pvt Ltd v.Cocosath Health Products
This original petition challenged an interim injunction granted by the Commercial Court, Ernakulam, which restrained Pranathmaka Ayurvedics Pvt Ltd from appointing exclusive global marketers and transferring confidential product know-how. The High Court dismissed the petition, holding that since the petitioners had not shown reason for not availing the statutory remedy of appeal under Section 13(1) of the Commercial Courts Act, 2015, it would not interfere with the lower court's order.
Karan Bajaj & Anr. v.Pradeep Poonia
The Delhi High Court granted interim relief in favor of Karan Bajaj & Anr. against Pradeep Poonia, addressing allegations of trademark infringement, copyright violation, defamation, and unauthorized access to confidential business data. The court restrained the defendant from using similar marks like 'WhiteHat Sr' and prohibited him from hacking or circulating the plaintiffs' proprietary curriculum. Furthermore, the judgment mandated the removal of multiple defamatory tweets and YouTube content posted by the respondent.
Astrazeneca Ab & Anr. v.Torrent Pharmaceuticals Ltd., Micro Labs Limited, Zydus Healthcare Ltd., ERIS Lifesciences Ltd., USV Pvt. Ltd., MSN Laboratories Pvt. Ltd.
The plaintiffs sought permanent and temporary injunctions against various defendants for infringing their patents related to Dapagliflozin. The court found that the defendants had laid a credible challenge to the validity of the suit patent, leading the court to decline the grant of interim injunction.
ASTRAZENCA AB & ANR v.AJANTA PHARMA LTD.
The plaintiffs filed a suit alleging infringement of their patent IN '625. The present order addressed the defendant's request for an early hearing, noting that in connected suits, the court had previously declined interim injunctions.
Sulphur Mills Limited v.M/s.Dayal Fertilizers Pvt. Limited
Sulphur Mills Limited appealed against an order that revoked its leave to sue M/s.Dayal Fertilizers Pvt. Limited and others regarding alleged patent infringement (Patent No.282429). The core issue before the Madras High Court was whether the suit fell within the court's territorial jurisdiction, given that the defendants operated outside the state. The court ultimately allowed the appeal, holding that the revocation of leave to sue was incorrect due to jurisdictional concerns.
Sulphur Mills Limited v.M/s.Dayal Fertilizers Pvt. Limited
Sulphur Mills Limited appealed against an order that revoked its leave to sue M/s.Dayal Fertilizers Pvt. Limited and others for alleged infringement of Patent No. 282429. The core issue revolved around whether the court had territorial jurisdiction, given that the defendants operated outside the local limits. The Madras High Court allowed the appeals, restoring the suit to the Commercial Division.
Havells India Limited v.Yash Fans Pvt. Ltd.
Havells India Limited filed a suit against Yash Fans Pvt. Ltd. for infringement of its design and passing off. The parties subsequently reached an amicable settlement, which was recorded by the court.
Unilever Plc. And Anr. v.Ashok Kumar (unknown person/s)
Unilever Plc. filed an interim application seeking ad-interim reliefs against an unknown defendant for the infringement of its registered trade marks (including LAKME and U-Logo), copyrights in artistic works, and passing off related to its FMCG products. The court granted immediate relief, empowering Additional Special Receivers to seize and seal all infringing goods.
Kent Ro Systems Ltd And Anr v.Dilip Kumar Shukla & Ors.
In this ongoing commercial suit concerning alleged infringement and passing off related to Kent RO's products, the court addressed a procedural challenge regarding one of the defendants. The defendant argued that the design right relevant to their involvement had expired, prompting the plaintiff to consider removing them from the case. While no final judgment was reached, the court issued several directions for the completion of pleadings and document exchange.
Dhaval Diyora v.Union of India And Ors
The petitioner challenged the order passed by the Intellectual Property Appellate Board (IPAB) which had directed the Controller to issue a patent to Pfizer Products Inc. The petitioner argued that this order was passed without giving him an opportunity to be heard regarding his pre-grant opposition. The court dismissed the writ petition, finding the petitioner's conduct questionable and holding that the pre-grant opposition was not maintainable in law.
Unilever Plc & Anr. v.Vikas Sachdeva
Plaintiffs, Unilever Plc & Anr., filed an interim application seeking ad-interim reliefs in a suit for infringement of their registered trademarks and copyrights. Plaintiffs alleged that the defendant was clandestinely marketing and selling cosmetic preparations bearing counterfeit marks (LAKME, LAKME 9 to 5, LAKME EYECONIC) and infringing artworks. The court granted an interim order appointing an Additional Special Receiver to seize and seal the infringing goods.
Astrazeneca Ab & Anr. v.Alkem Laboratories Limited
Astrazeneca sued Intas Pharmaceuticals Limited and Alkem Laboratories Limited regarding two patents, IN 147 (genus) and IN 625 (species), covering the SGLT2 inhibitor Dapagliflozin (DAPA). The core dispute was whether DAPA, which is used to treat type-II diabetes, falls within the scope of the genus patent. The court ultimately dismissed the plaintiffs' applications.
Unilever Plc. v.Ranbir Narang
Unilever Plc. filed an Interim Application concerning the counterfeiting of its goods, which bear multiple registered trade marks (like POND'S, HUL) and copyrighted artistic containers. The court granted ad-interim injunctions against both defendants to prevent further infringement and directed a receiver to seize all infringing materials.
Unilever Plc v.Rahul Goyal
Plaintiffs, Unilever Plc (and its subsidiary Plaintiff no.2), filed an interim application seeking ad-interim reliefs against Rahul Goyal for infringement of their trademarks (LAKME, U-Logo, etc.), copyrights in artistic works, and passing off related to cosmetic preparations. The court granted the interim relief, appointing an Additional Special Receiver to seize and seal the infringing goods.
Interdigital Technology Corporation & Ors. v.Xiaomi Corporation & Ors.
The plaintiffs filed an application before the Delhi High Court challenging an anti-suit injunction issued by the Wuhan Intermediate People's Court, which sought to restrain them from prosecuting their SEP royalty rate suit in India. The court found a clear case for granting ad interim relief.
Novartis Ag v.Torrent Pharmaceuticals Limited
The plaintiffs allege that the defendant's product infringes their patent for a pharmaceutical composition consisting of sacubitril and valsartan. The defendant claims their product is different and has filed for revocation of the suit patent.
Company v.State Pollution Control Board (SPCB)
The petitioner company filed a writ petition seeking protection for its patent related to the manufacturing process of hazardous waste materials (SPL). The petitioner argued that the SPCB's planned review of criteria could negatively impact its patented process and lead to closure due to insufficient raw material sanction. The Court disposed of the petition by directing the SPCB and CPCB to consider the pending representations and grant a hearing to the petitioner.
Astrazeneca Ab v.Emcure Pharmaceuticals Limited
The plaintiffs, AstraZeneca, allege that the defendants are infringing their patents related to the compound 'Dapagliflozin', used for treating type-2 diabetes. The plaintiffs seek an injunction against the defendants for not seeking licenses for the patents.
Astrazeneca Ab v.Emcure Pharmaceuticals Limited
The plaintiffs, AstraZeneca, allege that the defendants are infringing their patents related to the compound 'Dapagliflozin', used for treating type-2 diabetes. The plaintiffs seek an injunction against the defendants for not seeking licenses for the patents.
Astrazeneca Ab v.Emcure Pharmaceuticals Limited
The plaintiffs, AstraZeneca, allege that the defendants are infringing their patents related to the compound 'Dapagliflozin', used for treating type-2 diabetes. The case involves requests for injunctions against the defendants for not seeking licenses for the patents.
Worknest Business Centre Llp & Anr. v.M/S Worknests Through Rajesh Goyal
Worknest Business Centre LLP filed a suit alleging trademark and copyright infringement against M/S Worknests, claiming that the defendant's use of 'WORKNESTS' in the co-working space business infringed upon its established mark 'WORKNEST'. While the plaintiff presented evidence of prior domain registration and trademarks, the court found no immediate grounds to grant an interim injunction. The matter was directed to proceed as a full suit for detailed examination.
Indoco Remedies Ltd. v.Bristol Myers Squibb Holdings Ireland Unlimited Company
Indoco Remedies Ltd. filed an application seeking permission to sell approximately 58,000 strips of its generic product APIXABID (Apixaban), which had been manufactured prior to a restrictive injunction being passed by the Single Judge. The court dismissed the application, holding that without a decision on the merits, it could not reverse the findings of the learned Single Judge.
BASF SE v.UPL LIMITED
BASF SE filed a suit against UPL Limited seeking permanent injunction for infringing its India Patent No. 262428, which covers Boscalid anhydrous Form-II. The court considered affidavits from both parties regarding infringement and R&D activities. Ultimately, the court decreed the suit in favor of BASF SE, granting a permanent injunction.
Carneige Institute Of Washington v.Fenix Diamonds Llc
The application sought to execute a Letter Rogatory from the U.S. District Court for the Southern District New York, requesting deposition testimony, facility inspection, and document production related to patent infringement litigation concerning CVD diamonds. The court partially granted the request by appointing a Principal District Judge in Surat to record witness evidence.
Astrazeneca AB & Anr. v.Torrent Pharmaceuticals Ltd.
The plaintiffs presented an overview of their case. Since the defendant challenged the validity of the suit patent (IN-235625), the court directed the defendant to present arguments on that matter.
FMC Corporation v.Modern Insecticides Limited
FMC Corporation filed a suit alleging that Modern Insecticides Limited was infringing its valid Indian Patent (IN 201307) related to the insecticide Chlorantraniliprole (CTPR). The plaintiffs, who are co-owners of the patent, claimed that the defendant was manufacturing and exporting the compound, thereby violating their intellectual property rights. Based on the prima facie case presented by FMC Corporation, the Delhi High Court granted an ex-parte ad-interim injunction in favour of the plaintiffs.
ASTRAZENECA AB & ANR. v.MICRO LABS LIMITED
The plaintiff, AstraZeneca, filed a suit alleging infringement of its genus (IN 147) and species (IN 625) patents for the drug DAPAGLIFLOZIN (brand name FORXIGA). The defendant, Micro Labs Limited, was accused of manufacturing, selling, and seeking approval for generic versions. The court granted an ex-parte ad-interim injunction in favour of the plaintiff.
Astrazenca Ab v.West Coast Pharmaceuticals Works Ltd.
Astrazenca filed a suit alleging that West Coast Pharmaceuticals Works Ltd. was manufacturing the drug Dapagliflozin, which is protected by Astrazenca's patents (IN '147 and IN '625). The defendant entered an undertaking acknowledging the validity of the patents and agreeing not to infringe them.
Novartis Ag & Anr v.Natco Pharma Limited
The plaintiffs sought revival of an earlier interim order restraining the defendant from manufacturing pharmaceutical preparations comprising 'Ceritinib'. The court noted that the initial order was suspended due to the suit patent being revoked. However, since the IPAB subsequently stayed the revocation order, the court revived the original ad interim relief.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.